UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract BL2: The Molecular Etiology of Luminal-Type Breast Cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.BL2-BL2

Ellis, MJ

2020

Volltextzugriff (PDF)

Abstract TS1-3: Proteogenomics and Clinical Translation

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.TS1-3-TS1-3

Ellis, MJ

2020

Volltextzugriff (PDF)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

JNCI : Journal of the National Cancer Institute, 2021-07, Vol.113 (7), p.808-819

2021

Volltextzugriff (PDF)

Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers

Clinical cancer research, 2018-10, Vol.24 (19), p.4887-4899

2018

Volltextzugriff (PDF)

Endovascular therapy in children with acute ischemic stroke: review and recommendations

Neurology, 2012-09, Vol.79 (13 Suppl 1), p.S158

2012

Volltextzugriff (PDF)

Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen

Annals of oncology, 2012-11, Vol.23 (11), p.2866-2873

2012

Volltextzugriff (PDF)

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

The New England journal of medicine, 2004-08, Vol.351 (8), p.781-791

2004

Volltextzugriff (PDF)

Abstract PD7-08: Immune checkpoint upregulation and T-cell exhaustion in aggressive hormone-receptor positive breast cancer patients

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD7-08-PD7-08

2019

Volltextzugriff (PDF)

Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer

Journal of clinical oncology, 2005-03, Vol.23 (7), p.1420-1430

2005

Volltextzugriff (PDF)

Abstract PD5-09: Fulvestrant for hormone receptor-positive advanced breast cancer in patients with visceral vs non-visceral metastases: Findings from FALCON, FIRST, and CONFIRM

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD5-09-PD5-09

2018

Volltextzugriff (PDF)

Abstract P4-12-04: Cost-effectiveness analysis of locally advanced estrogen receptor-positive, HER-2 negative breast cancer care using a tailored treatment approach in Brazil

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P4-P4-12-04

2018

Volltextzugriff (PDF)

Abstract P1-06-02: Mismatch repair protein loss in breast cancer: Clinicopathological associations in a large British Columbia cohort

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-06-02

2019

Volltextzugriff (PDF)

A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy

Breast cancer research and treatment, 2021-08, Vol.189 (1), p.15-23

2021

Volltextzugriff (PDF)

Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas

Journal of clinical oncology, 2005-08, Vol.23 (23), p.5305-5313

2005

Volltextzugriff (PDF)

Chronic Kidney Disease After Hematopoietic Cell Transplantation: A Systematic Review

American journal of transplantation, 2008-11, Vol.8 (11), p.2378-2390

2008

Volltextzugriff (PDF)

Abstract P2-08-02: Progression-free survival results in patient subgroups from a Phase 3 randomized trial of fulvestrant 500 mg vs anastrozole for hormone receptor-positive advanced breast cancer (FALCON)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-08-02

2017

Volltextzugriff (PDF)

Abstract P2-08-09: Progression-free survival results in postmenopausal Asian women: Subgroup analysis from a phase 3 randomized trial of fulvestrant 500 mg vs anastrozole for hormone receptor-positive advanced breast cancer (FALCON)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-08-09

2017

Volltextzugriff (PDF)

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

Journal of clinical oncology, 2001-09, Vol.19 (18), p.3808-3816

2001

Volltextzugriff (PDF)

Hfq restructures RNA-IN and RNA-OUT and facilitates antisense pairing in the Tn10/IS10 system

RNA (Cambridge), 2013-05, Vol.19 (5), p.670-684

2013

Volltextzugriff (PDF)

Abstract P5-06-01: Proteomic analysis of conserved kinases between PDX tumors and corresponding PDX-derived cell lines

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-06-01

2018

Volltextzugriff (PDF)

Abstract P2-09-19: Genomic biomarker for resistance to palbociclib in the NeoPalAna trial

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-09-19

2018

Volltextzugriff (PDF)

Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent

Transplantation, 2013-07, Vol.96 (1), p.91-96

2013

Volltextzugriff (PDF)

Abstract P5-04-01: Functional and therapeutic significance of ESR1 fusions in metastatic ER+ breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-04-01

2019

Volltextzugriff (PDF)

Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies

Journal of clinical oncology, 2005-04, Vol.23 (11), p.2502-2512

2005

Volltextzugriff (PDF)

1 – 25 von 743

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(682)
Mit Volltextzugriff
(600)

Publikationsform

Sprache

Englisch
(743)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(595)
Life Sciences & Biomedicine
(463)
Humans
(284)
Biological And Medical Sciences
(223)
Female
(183)
Medical Sciences
(151)
Male
(147)
Animals
(130)
Physical Sciences
(114)
Middle Aged
(83)
Adult
(81)
Fundamental And Applied Biological Sciences. Psychology
(78)
Oncology
(65)
Biochemistry & Molecular Biology
(58)
Technology
(56)
Pharmacology. Drug Treatments
(51)
Physics
(48)
Aged
(44)
Exact Sciences And Technology
(43)
Chemistry
(41)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(416)
EZB Electronic Journals Library
(353)
Publisher website
(276)
Ingenta.com
(268)
Journals@Ovid Full Text
(255)
Elsevier ScienceDirect Journals Complete
(143)
Wiley-Blackwell Journals
(120)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(105)
Wiley Online Library
(91)
IngentaConnect Journals
(87)
Springer journals
(52)
Oxford journals
(49)
JSTOR
(40)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(32)
Taylor & Francis Journals
(27)
Taylor & Francis
(26)
Taylor & Francis Online
(23)
Oxford Journals 2020 Medicine
(19)
Nature
(18)
Nexis Uni
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Abstract BL2: The Molecular Etiology of Luminal-Type Breast Cancer

Abstract TS1-3: Proteogenomics and Clinical Translation

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

Proteogenomics connects somatic mutations to signalling in breast cancer

Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers

Endovascular therapy in children with acute ischemic stroke: review and recommendations

Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Abstract PD7-08: Immune checkpoint upregulation and T-cell exhaustion in aggressive hormone-receptor positive breast cancer patients

Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer

Abstract PD5-09: Fulvestrant for hormone receptor-positive advanced breast cancer in patients with visceral vs non-visceral metastases: Findings from FALCON, FIRST, and CONFIRM

Abstract P4-12-04: Cost-effectiveness analysis of locally advanced estrogen receptor-positive, HER-2 negative breast cancer care using a tailored treatment approach in Brazil

Abstract P1-06-02: Mismatch repair protein loss in breast cancer: Clinicopathological associations in a large British Columbia cohort

A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy

Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas

Chronic Kidney Disease After Hematopoietic Cell Transplantation: A Systematic Review

Abstract P2-08-02: Progression-free survival results in patient subgroups from a Phase 3 randomized trial of fulvestrant 500 mg vs anastrozole for hormone receptor-positive advanced breast cancer (FALCON)

Abstract P2-08-09: Progression-free survival results in postmenopausal Asian women: Subgroup analysis from a phase 3 randomized trial of fulvestrant 500 mg vs anastrozole for hormone receptor-positive advanced breast cancer (FALCON)

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

Hfq restructures RNA-IN and RNA-OUT and facilitates antisense pairing in the Tn10/IS10 system

Abstract P5-06-01: Proteomic analysis of conserved kinases between PDX tumors and corresponding PDX-derived cell lines

Abstract P2-09-19: Genomic biomarker for resistance to palbociclib in the NeoPalAna trial

Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent

Abstract P5-04-01: Functional and therapeutic significance of ESR1 fusions in metastatic ER+ breast cancer

Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies

Suchergebnisse filtern